Chemical Structure (Docetaxel 01)
Docetaxel Injection, Solution, Concentrate
Product Images NDC 0955-1021
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 0955-1021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Docetaxel 02)
This appears to be a graph depicting Disease-Free Survival Probability (in percentage) over time (in months). The x-axis shows the time period in months, with data points every 6 months, and the y-axis shows the probability of survival without disease. The graph shows a probability of 100% at the first time point and decreases as time progresses. However, without additional information or context, it is difficult to determine the exact meaning or relevance of this graph.*
Figure 2 (Docetaxel 03)
This is a chart displaying the survival probability in percentage (%) over time in months. The survival probability starts at 100% and the chart shows the percentage at different intervals of 6 months up to 48 months.*
Figure 3 (Docetaxel 04)
This text appears to be a graph or chart related to the "Cumulative Probability" of "Overall Survival" over time in months. It also includes a statistical value of "Logrank p=0010". It is likely part of a larger report or study analyzing survival rates for a particular population or illness.*
Figure 4 (Docetaxel 05)
This is a graph showing cumulative probability vs survival time in months, with a range of 0 to 59 months. The graph is not fully shown in the given text, with only the axis labels visible.*
Figure 5 (Docetaxel 06)
It seems like a graph or chart representing survival probability based on survival time in months. However, without the accompanying graph or chart, it is difficult to provide further information.*
Figure 6 (Docetaxel 07)
Figure 7 (Docetaxel 08)
Figure 8 (Docetaxel 09)
This text is describing a graph or chart showing the probability of Progression Free Survival Time (months) over some period of time. The graph may be showing a 12-month duration, but it is unclear as the rest of the text is not available.*
Figure 9 (Docetaxel 10)
Survival probability data is provided, however, the numbers appear to be partially unreadable and don't make sense. The second line mentions "Survival Time" in months. It is unclear what this data relates to or what it represents.*
Figure 10 (Docetaxel 11)
Principal Display Panel (4 mL Vial Carton)
This is a description of a medication called Docetaxel. It is a ready to add to the infusion solution for intravenous use. The Docetaxel comes in a single-dose vial containing 20 mg/mL and is recommended to be discarded after use. It has a NOC number (0985102104) and is manufactured by Winthrop, a subsidiary of Sanofi. The other text is difficult to understand and lacks context.*
Principal Display Panel (1 mL Vial Carton)
This is a product label for Docetaxel injection manufactured by Winthrop for intravenous infusion only. Each vial contains a 20mg/mL solution to be used as a single-dose and any unused portion should be discarded. The product is intended for Rx-only use and the label has various identification numbers associated with it.*
Principal Display Panel (8 mL Vial Carton)
This is a medication label for a single-dose vial of Docetaxel Injection by Winthrop, with a strength of 150mg/gmL. It is intended for intravenous infusion only and the unused portion must be discarded. The label contains various codes and numbers, but there is no useful description.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
